Detalles de la búsqueda
1.
Prostate-specific antigen (PSA) decline with apalutamide therapy is associated with longer survival and improved outcomes in individuals with metastatic prostate cancer: a plain language summary of the TITAN study.
Future Oncol
; 20(10): 563-578, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38126311
2.
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.
N Engl J Med
; 381(1): 13-24, 2019 07 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31150574
3.
Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer: Analysis of Pain and Fatigue in the Phase 3 TITAN Study.
J Urol
; 206(4): 914-923, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34039013
4.
Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study.
Lancet Oncol
; 20(11): 1518-1530, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31578173
6.
Efficacy and safety of MCNA in patients with nonmuscle invasive bladder cancer at high risk for recurrence and progression after failed treatment with bacillus Calmette-Guérin.
J Urol
; 193(4): 1135-43, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25286009
7.
Cryoablation for locally advanced clinical stage T3 prostate cancer: a report from the Cryo-On-Line Database (COLD) Registry.
BJU Int
; 113(5): 714-8, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24112776
8.
Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: A subgroup analysis of the randomised clinical TITAN study.
Eur J Cancer
; 193: 113290, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37708629
9.
Achieving the 'bifecta' using salvage cryotherapy for locally recurrent prostate cancer: analysis of the Cryo On-Line Data (COLD) registry data.
BJU Int
; 110(2): 217-20, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21992443
10.
Guidelines for Management of Treatment-Emergent Adverse Events During Rucaparib Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer.
Cancer Manag Res
; 14: 673-686, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35210863
11.
Concomitant use of oral anticoagulants in patients with advanced prostate cancer receiving apalutamide: A post-hoc analysis of TITAN and SPARTAN studies.
Am J Cancer Res
; 12(1): 445-450, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35141028
12.
Does the type of cryoprobe affect oncological and functional outcomes in men with clinically localized prostate cancer treated with primary whole gland prostate cryoablation?
Curr Urol
; 15(2): 79-84, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34168524
13.
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study.
J Clin Oncol
; 39(20): 2294-2303, 2021 07 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33914595
14.
Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer.
J Urol
; 183(5): 1822-8, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20303100
15.
Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR study.
Urol Oncol
; 36(2): 81.e9-81.e16, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29150328
16.
Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
J Endourol
; 21(12): 1521-31, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18186694
17.
Use of a 17-Gene Prognostic Assay in Contemporary Urologic Practice: Results of an Interim Analysis in an Observational Cohort.
Urology
; 107: 67-75, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28454985
18.
Prostate Specific Antigen Nadir of 0.1 or Less Is a Predictor of Treatment Success in Men Undergoing Salvage Whole Prostate Gland Cryoablation.
J Endourol
; 31(5): 497-501, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28437170
19.
Prospective longitudinal comparative study of early health-related quality-of-life outcomes in patients undergoing surgical treatment for localized prostate cancer: a short-term evaluation of five approaches from a single institution.
J Endourol
; 20(10): 723-31, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17094746
20.
Primary Cryotherapy for High-Grade Clinically Localized Prostate Cancer: Oncologic and Functional Outcomes from the COLD Registry.
J Endourol
; 30(1): 43-8, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26414656